Accessibility Menu
Treace Medical Concepts logo

Treace Medical Concepts

(NASDAQ) TMCI

Current Price$4.32
Market Cap$289.33M
Since IPO (2021)-83%
5 Year-86%
1 Year-26%
1 Month+23%

Treace Medical Concepts Financials at a Glance

Market Cap

$289.33M

Revenue (TTM)

$207.32M

Net Income (TTM)

-$61.04M

EPS (TTM)

-$0.96

P/E Ratio

-4.66

Dividend

$0.00

Beta (Volatility)

1.29 (Average)

Price

$4.32

Volume

1,060,259.001

Open

$4.52

Previous Close

$4.27

Daily Range

$4.24 - $4.56

52-Week Range

$1.17 - $7.78

Estimated Earnings Date

Aug 6, 2026

TMCI: Motley Fool Moneyball Superscore

45

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Treace Medical Concepts

Industry

Healthcare Equipment and Supplies

Employees

450

CEO

John T. Treace

Headquarters

Ponte Vedra, FL 32081, US

TMCI Financials

Key Financial Metrics (TTM)

Gross Margin

79.72%

Operating Margin

-26.89%

Net Income Margin

-29.44%

Return on Equity

-69.50%

Return on Capital

-53.45%

Return on Assets

-33.16%

Earnings Yield

-21.46%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$289.33M

Shares Outstanding

64.87M

Volume

1.06M

Avg. Volume

892.12K

Financials (TTM)

Gross Profit

$165.27M

Operating Income

-$55.74M

EBITDA

-$46.33M

Operating Cash Flow

-$12.93M

Capital Expenditure

-$13.04M

Free Cash Flow

-$25.97M

Cash & ST Invst.

$51.85M

Total Debt

$13.55M

Treace Medical Concepts Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$47.20M

-10.2%

Gross Profit

$37.41M

-10.7%

Gross Margin

79.26%

N/A

Market Cap

$289.33M

N/A

Market Cap/Employee

$669.75K

N/A

Employees

432

N/A

Net Income

-$17.96M

-12.8%

EBITDA

-$15.49M

-27.5%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$51.85M

-31.9%

Total Debt

$13.55M

-80.5%

Accounts Receivable

$30.36M

-2.4%

Inventory

$36.37M

-4.1%

Long Term Debt

$13.55M

-79.9%

Short Term Debt

$0.00

-100.0%

Return on Assets

-33.16%

N/A

Return on Invested Capital

-37.26%

N/A

Free Cash Flow

$4.17M

+536.9%

Operating Cash Flow

$7.23M

+72.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
LABStandard BioTools Inc.
$0.75+1.80%
SMLRSemler Scientific, Inc.
$20.33-4.87%
RXSTRxSight, Inc.
$5.10-4.85%
EOLSEvolus, Inc.
$7.13+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
CMCSAComcast
$24.22+0.05%
NOKNokia
$13.03+0.00%
SMCISuper Micro Computer
$28.15-0.08%
TAT&T
$21.82-0.04%

Questions About TMCI

What is the current price of Treace Medical Concepts?

Treace Medical Concepts is trading at $4.27 per share.

What is the 52-week range for Treace Medical Concepts?

Over the past 52 weeks, Treace Medical Concepts has traded between $1.17 and $7.78.

How much debt does Treace Medical Concepts have?

As of the most recent reporting period, Treace Medical Concepts reported total debt of $71.60M.

How much cash does Treace Medical Concepts have on hand?

Treace Medical Concepts reported $9.54M in cash and cash equivalents in its most recent financial results.

What is Treace Medical Concepts’s dividend yield?

Treace Medical Concepts does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.